Long-term follow-up of recovered MPN patients with COVID-19-Reference-Cited by-同舟云学术

Long-term follow-up of recovered MPN patients with COVID-19

Published:2021-06 Issue:6 Volume:11 Page:
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer J.

Author:

Barbui Tiziano^ORCID,Iurlo Alessandra^ORCID,Masciulli Arianna,Carobbio Alessandra^ORCID,Ghirardi Arianna,Rossi Giuseppe,Harrison Claire,Alvarez-Larran Alberto,Elli Elena Maria,Kiladjian Jean-Jaques,Gasior Kabat Mercedes,Marin Sanchez Alberto,Palandri Francesca^ORCID,Andrade-Campos Marcio Miguel,Vannucchi Alessandro Maria,Carreno-Tarragona Gonzalo^ORCID,Papadopoulos Petros,Quiroz Cervantes Keina^ORCID,Angeles Foncillas Maria^ORCID,Fox Maria Laura,Sagues Serrano Miguel,Rumi Elisa^ORCID,Osorio Santiago,Benevolo Giulia,Patriarca Andrea^ORCID,Navas Elorza Begona,Garcia-Gutierrez Valentin,Magro Mazo Elena,Lunghi Francesca,Bonifacio Massimiliano^ORCID,De Stefano Valerio^ORCID,Hernandez-Boluda Juan Carlos^ORCID,Lopez Abadia Emma,Angona Anna,Xicoy Cirici Blanca,Ruggeri Marco,Koschmieder Steffen^ORCID,Sobas Marta Anna,Cuevas Beatriz^ORCID,Cattaneo Daniele,Daffini Rosa,Bellini Marta,Curto-Garcia Natalia,Garrote Marta,Cavalca Fabrizio,Benajiba Lina,Bellosillo Beatriz,Guglielmelli Paola^ORCID,Borsani Oscar^ORCID,Betti Silvia,Salmoiraghi Silvia,Rambaldi Alessandro^ORCID

Funder

BREMBO SpA, Grant "COVID 3x1 projects"

Associazione Italiana per la Ricerca sul Cancro

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/s41408-021-00509-0.pdf

Reference11 articles.

1. Barbui T, Vannucchi AM, Alvarez-Larran A, Iurlo A, Masciulli A, Carobbio A, et al. High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib. Leukemia. 2021;35:485–93.

2. Barbui T, De Stefano V, Alvarez-Larran A, Iurlo A, Masciulli A, Carobbio A, et al. Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19. Blood Cancer J. 2021;11:21.